I looked up the purpose of a 10-Q using several references, all state that it is simply used for reporting the financial position of the company. Now while you can argue that receiving FDA approval or denial greatly impacts their financial position, it really has no direct monetary impact unless they sell something, receive grants, etc...
However, I feel that if they received FDA approval, they would have also received some type of grant or funding agreement which would be reported on the 10-Q. This would all but force Koos to issue a PR before the release of the 10-Q. If we don't hear anything before or immediately after the 10-Q, I would start to get nervous!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.